Perpetual Ltd lifted its position in Lam Research Corporation (NASDAQ:LRCX – Free Report) by 92.5% in the 3rd quarter, HoldingsChannel reports. The firm owned 18,941 shares of the semiconductor company’s stock after purchasing an additional 9,101 shares during the quarter. Perpetual Ltd’s holdings in Lam Research were worth $2,536,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other large investors have also recently bought and sold shares of the company. IMG Wealth Management Inc. purchased a new position in Lam Research during the 2nd quarter worth approximately $26,000. Howard Hughes Medical Institute acquired a new stake in shares of Lam Research in the second quarter worth $27,000. Strategic Wealth Investment Group LLC purchased a new position in shares of Lam Research during the second quarter worth $29,000. Delos Wealth Advisors LLC acquired a new position in Lam Research during the second quarter valued at $30,000. Finally, REAP Financial Group LLC purchased a new stake in Lam Research in the second quarter valued at $31,000. Hedge funds and other institutional investors own 84.61% of the company’s stock.
Wall Street Analyst Weigh In
Several brokerages have recently issued reports on LRCX. Mizuho boosted their price objective on Lam Research from $170.00 to $200.00 and gave the company an “outperform” rating in a report on Wednesday. Weiss Ratings reissued a “buy (b)” rating on shares of Lam Research in a report on Monday, December 15th. B. Riley upped their price objective on Lam Research from $180.00 to $195.00 and gave the stock a “buy” rating in a research report on Thursday. BNP Paribas Exane boosted their target price on shares of Lam Research from $80.00 to $140.00 and gave the company a “neutral” rating in a research note on Thursday, October 23rd. Finally, Jefferies Financial Group restated a “buy” rating and set a $200.00 price target (up previously from $175.00) on shares of Lam Research in a research report on Monday, December 15th. Twenty-six investment analysts have rated the stock with a Buy rating and ten have given a Hold rating to the company. According to data from MarketBeat, Lam Research currently has a consensus rating of “Moderate Buy” and an average price target of $160.37.
Lam Research Price Performance
Shares of NASDAQ LRCX opened at $172.27 on Friday. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.60 and a current ratio of 2.21. The firm has a fifty day moving average of $154.83 and a 200 day moving average of $123.08. The firm has a market cap of $216.38 billion, a PE ratio of 37.95, a PEG ratio of 1.77 and a beta of 1.77. Lam Research Corporation has a one year low of $56.32 and a one year high of $173.58.
Lam Research (NASDAQ:LRCX – Get Free Report) last announced its earnings results on Wednesday, October 22nd. The semiconductor company reported $1.26 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.22 by $0.04. The business had revenue of $5.32 billion for the quarter, compared to analyst estimates of $5.23 billion. Lam Research had a net margin of 29.66% and a return on equity of 60.60%. The company’s revenue for the quarter was up 27.7% compared to the same quarter last year. During the same quarter last year, the business earned $0.86 earnings per share. Lam Research has set its Q2 2026 guidance at 1.050-1.250 EPS. As a group, research analysts predict that Lam Research Corporation will post 3.71 EPS for the current fiscal year.
Lam Research Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Wednesday, January 7th. Shareholders of record on Wednesday, December 3rd will be issued a dividend of $0.26 per share. The ex-dividend date of this dividend is Wednesday, December 3rd. This represents a $1.04 dividend on an annualized basis and a dividend yield of 0.6%. Lam Research’s dividend payout ratio is presently 22.91%.
Insider Transactions at Lam Research
In other Lam Research news, insider Ava Harter sold 9,010 shares of the firm’s stock in a transaction on Monday, October 27th. The stock was sold at an average price of $157.47, for a total value of $1,418,804.70. Following the transaction, the insider owned 56,786 shares in the company, valued at approximately $8,942,091.42. This trade represents a 13.69% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director Bethany Mayer sold 1,298 shares of the company’s stock in a transaction on Monday, November 3rd. The stock was sold at an average price of $159.99, for a total transaction of $207,667.02. Following the sale, the director directly owned 1,652 shares of the company’s stock, valued at $264,303.48. The trade was a 44.00% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last ninety days, insiders have sold 102,608 shares of company stock worth $14,916,496. 0.31% of the stock is owned by insiders.
Key Headlines Impacting Lam Research
Here are the key news stories impacting Lam Research this week:
- Positive Sentiment: Multiple sell‑side upgrades and price‑target increases from major firms lift sentiment and implied upside — B. Riley raised its target to $195 and maintained a buy rating. Article Title
- Positive Sentiment: Deutsche Bank raised its target to $195 and reiterated a buy, citing stronger forward visibility; that adds another institutional vote of confidence. Article Title
- Positive Sentiment: Mizuho lifted its price target to $200 from $170, maintaining an outperform view — another sizable increase that signals analysts expect stronger 2026 demand. Article Title
- Positive Sentiment: Coverage roundup: three firms turned bullish on LRCX today, a concentrated shift that drove short‑term buying interest. Article Title
- Positive Sentiment: Technical momentum: LRCX just flashed a golden‑cross (longer MA crossing above shorter MA) and cleared the 20‑day moving average — a buy signal that attracts momentum traders. Article Title
- Positive Sentiment: Investor recognition: IBD named Lam an “IBD Stock of the Day” and noted all‑time high momentum tied to 2026 prospects, which can attract retail inflows. Article Title
- Neutral Sentiment: Analysis pieces and price‑range summaries reflect consensus views and model updates (price forecasts shown from ~$175 to $210) — useful context but not a direct catalyst on its own. Article Title
- Neutral Sentiment: Feature coverage (Forbes) reviews the drivers behind today’s move and the 2026 thesis; good background for investors but largely descriptive. Article Title
- Neutral Sentiment: Corporate/community items (annual collegiate challenge winners) are positive PR but unlikely to move the stock materially. Article Title
About Lam Research
Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.
Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.
Featured Stories
- Five stocks we like better than Lam Research
- How to Choose Top Rated Stocks
- These 3 Banks Are Rallying Into Year-End, But Will It Continue?
- Where to Find Earnings Call Transcripts
- 3 Surging Stocks Just Got the Ultimate Stamp of Approval From the S&P 500
- 3 Healthcare Dividend Stocks to Buy
- This ETF Caught a Major Tailwind After the Fed’s Rate Cut
Want to see what other hedge funds are holding LRCX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Lam Research Corporation (NASDAQ:LRCX – Free Report).
Receive News & Ratings for Lam Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lam Research and related companies with MarketBeat.com's FREE daily email newsletter.
